| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.450 | 34.950 | 81.554 | 61.563 | 59.721 | 59.953 | 36.387 | 58.806 | 0 | 0 |
| Total Income - EUR | 60.989 | 41.988 | 81.554 | 61.563 | 59.721 | 59.953 | 36.387 | 58.806 | 0 | 0 |
| Total Expenses - EUR | 22.328 | 39.634 | 59.556 | 17.560 | 16.830 | 15.691 | 13.441 | 15.632 | 22.462 | 8.033 |
| Gross Profit/Loss - EUR | 38.661 | 2.353 | 21.998 | 44.003 | 42.891 | 44.263 | 22.946 | 43.174 | -22.462 | -8.033 |
| Net Profit/Loss - EUR | 38.206 | 2.003 | 20.913 | 42.156 | 41.099 | 42.464 | 21.855 | 41.410 | -22.462 | -8.033 |
| Employees | 2 | 5 | 5 | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Medisana Lab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 102.515 | 100.609 | 86.913 | 70.906 | 55.586 | 41.112 | 27.695 | 16.324 | 5.994 | 768 |
| Current Assets | 26.333 | 41.665 | 61.062 | 53.415 | 93.443 | 117.567 | 145.430 | 215.236 | 204.858 | 19.159 |
| Inventories | 638 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 18.402 | 20.839 | 55.692 | 53.021 | 93.342 | 117.265 | 145.259 | 214.991 | 203.785 | 18.974 |
| Cash | 7.294 | 20.825 | 5.370 | 394 | 101 | 302 | 170 | 244 | 1.073 | 186 |
| Shareholders Funds | 23.202 | 24.968 | 43.494 | 52.707 | 78.358 | 89.197 | 109.073 | 219.126 | 195.134 | 11.199 |
| Social Capital | 45 | 45 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 105.647 | 117.305 | 64.867 | 32.727 | 32.537 | 32.071 | 27.470 | 12.434 | 15.718 | 8.728 |
| Income in Advance | 0 | 40.296 | 39.614 | 38.887 | 38.134 | 37.411 | 36.582 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medisana Lab Srl